2021 clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with peripheral spondyloarthritis. Colombian Association of Rheumatology

Saldarriaga-Rivera, Lina María; Bautista-Molano, W.; Junca-Ramírez, Alejandro; Fernández-Aldana, Andrés R.; Fernández-Ávila, Daniel G.; Jaimes, Diego Alejandro Rojas; Jáuregui, Edwin; Segura-Charry, Juan S.; Romero-Sánchez, Consuelo; Felipe-Diaz, Oscar J.

doi:10.1016/j.rcreue.2021.07.002

Cited by 1 publication

(1 citation statement)

References 83 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The continuum of axial spondyloarthritis (axSpA) is an expanding field in rheumatology practice. The emerging terminology classifies axSpA in radiographic (r-axSpA) and non-radiographic (r-axSpA) [ 1 , 2 ]. AxSpA presents a high societal burden predominantly affecting patients during their most productive years, usually younger than 45 years old, who may present a higher risk of comorbidities [ 1 , 3 , 4 ].…”

Section: Introductionmentioning

confidence: 99%

Prevalence of axial spondyloarthritis in Colombia: data from the National Health Registry 2017–2021

Barahona-Correa,

Herrera-Leaño,

Bernal-Macías

et al. 2023

Clin Rheumatol

View full text Add to dashboard Cite

Introduction Registries allow ascertaining the epidemiology of chronic diseases such as axial spondyloarthritis (axSpA). The Colombian Ministry of Health has implemented a National Health Registry (SISPRO) that collects data from each medical contact in the system, which provides close to universal coverage (around 98%). Objective To establish the 5-year prevalence of axSpA in Colombia, and to describe its demographics, using data from January 1st, 2017, to December 31st, 2021. Methods We performed an observational, cross-sectional study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to ax-SpA, based on SISPRO data. We estimated the prevalence using three approaches: (1) ankylosing spondylitis (AS) diagnoses; (2) diagnoses compatible with axSpA; and (3) diagnoses compatible with axSpA, including sacroiliitis. We calculated prevalence per 100,000 inhabitants. Results Based on our three approaches, patients with a primary diagnosis compatible with ax-SpA ranged between 12,684 and 117,648, with an estimated 5-year adjusted prevalence between 26.3 and 244 cases per 100,000 inhabitants (0.03–0.2%). The male-to-female ratio ranged between 1.2:1 and 0.4:1, which was markedly skewed towards a higher prevalence in women when we included the code for sacroiliitis. We found the highest frequency of cases in the 50–54 years group. A differential prevalence was observed between different regions in our country, particularly in regions known to have European ancestors. Conclusion This is the first study that describes demographic characteristics of ax-SpA in Colombia and offers valuable information for stakeholders. Key Points• Using the official country-level health database, the prevalence of axSpA in Colombia ranges between 26.3 and 244 cases per 100,000 inhabitants (0.03% - 0.2%)• The prevalence of axSpA peaked among the 50-54 years patient group, suggesting an increased survival• Nations with a substantial admixture, such as Colombia, may present a differential prevalence of axSpA among regions within the country• Including the ICD-10 code for sacroiliitis (M46.1) in epidemiological studies probably overestimates the frequency of axSpA

show abstract